Owners, management and financials
CVR: 41554908
Previous names: Copenhagen Bio Partners A/S
DKK -15,518,420
Gross profit
Net result: DKK -127,801,300
Novo Holdings A/S (33,33-49,99%), NOVOZYMES A/S (33,33-49,99%)
1 more
CVR · view owners
Henrik Marcus Geertz-Hansen, Jose Arnau Martinez
3 more in management
Board: Anders Bendsen Spohr (chair) and 4 members
CVR · view management
Active
Founded 1 August 2020
CVR · view overview
58 employees
Annual report 2025 · average
Director registered: Jose Arnau Martinez
CVR · 06/01/2025
View the full event history
21st.BIO A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Copenhagen Bio Partners A/S. The management consists of Henrik Marcus Geertz-Hansen, Jose Arnau Martinez and Mikael Bechsgaard. The board consists of Anders Bendsen Spohr (chair), Claus Crone Fuglsang, Thomas Dal Stenfeldt Batchelor and Thomas Grotkjær. The company is owned by Novo Holdings A/S, NOVOZYMES A/S and Momentum Techinvest ApS. According to the 2025 annual report, the company had an average of 58 employees. In 2025, the company reported a gross profit of DKK -15,518,420 and a net result of DKK -127,801,300 compared with DKK -41,660,123 the year before. Equity in the 2025 report amounted to DKK 202,530,839.
Selskabets formål er rådgivning om, investering i og udvikling af industrielle biotech-løsninger samt aktiviteter, der efter bestyrelsens skøn er forbundet dermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -15.5 mio. | -127.8 mio. | 341 mio. | 202.5 mio. | 58 | |
| 202401/01/2024 – 31/12/2024 | -17.2 mio. | -41.7 mio. | 440.9 mio. | 330.3 mio. | 19 | |
| 202301/01/2023 – 31/12/2023 | -9.8 mio. | -42.3 mio. | 419.2 mio. | 294.8 mio. | 32 | |
| 202201/01/2022 – 31/12/2022 | -21.9 mio. | -36.6 mio. | 329.4 mio. | 262.6 mio. | 11 |
Compared to 1.483 companies in Anden teknisk rådgivning
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of 21st.BIO A/S is 41554908.
21st.BIO A/S is owned by Novo Holdings A/S, NOVOZYMES A/S and Momentum Techinvest ApS.
The management of 21st.BIO A/S consists of Henrik Marcus Geertz-Hansen, Jose Arnau Martinez and Mikael Bechsgaard.
The board of 21st.BIO A/S consists of Anders Bendsen Spohr, Claus Crone Fuglsang and Thomas Dal Stenfeldt Batchelor, with Anders Bendsen Spohr as chair.
In 2025, 21st.BIO A/S reported a gross profit of DKK -15,518,420.
21st.BIO A/S had an average of 58 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
21st.BIO A/S has published its annual report for 2025. Gross profit came to DKK -15,518,420, and the net result was DKK -127,801,300.
Contact info changed: new email: [email protected], new website: 21st.bio (June 18, 2026).
21st.BIO A/S has published its annual report for 2024. Gross profit came to DKK -17,202,758, and the net result was DKK -41,660,123.
As of February 6, 2025, Anders Bendsen Spohr has joined the board of directors of 21st.BIO A/S.
As of February 6, 2025, Søren Møller has left the board of directors of 21st.BIO A/S.
As of January 6, 2025, Jose Arnau Martinez is registered as director of 21st.BIO A/S.
As of January 6, 2025, Henrik Marcus Geertz-Hansen is registered as director of 21st.BIO A/S.
As of January 6, 2025, Per Falholt has stepped down as director of 21st.BIO A/S.
As of January 6, 2025, Thorvald Uhrskov Ullum has stepped down as director of 21st.BIO A/S.
As of July 31, 2024, Novo Holdings A/S is registered as an owner of 21st.BIO A/S with an ownership share of 33%.
21st.BIO A/S has published its annual report for 2023. Gross profit came to DKK -9,825,858, and the net result was DKK -42,260,118.
As of November 1, 2023, Mikael Bechsgaard is registered as director of 21st.BIO A/S.
As of September 5, 2023, Thomas Grotkjær has joined the board of directors of 21st.BIO A/S.
As of September 5, 2023, Thomas Dal Stenfeldt Batchelor has joined the board of directors of 21st.BIO A/S.
As of September 5, 2023, Anders Bendsen Spohr has left the board of directors of 21st.BIO A/S.
As of September 5, 2023, Amy Louise Byrick has left the board of directors of 21st.BIO A/S.
21st.BIO A/S has published its annual report for 2022. Gross profit came to DKK -21,930,501, and the net result was DKK -36,612,241.
As of September 30, 2022, Claus Crone Fuglsang has joined the board of directors of 21st.BIO A/S.
As of September 30, 2022, Amy Louise Byrick has joined the board of directors of 21st.BIO A/S.
As of September 30, 2022, NOVOZYMES A/S is registered as an owner of 21st.BIO A/S with an ownership share of 33%.
As of September 30, 2022, Momentum Techinvest ApS is registered as an owner of 21st.BIO A/S with an ownership share of 5%.
As of August 10, 2022, Thorvald Uhrskov Ullum is registered as director of 21st.BIO A/S.
21st.BIO A/S has published its interim report for the period August 1, 2020 – December 31, 2021.
As of January 1, 2022, Per Falholt is registered as director of 21st.BIO A/S.
As of December 17, 2021, Anders Bendsen Spohr has joined the board of directors of 21st.BIO A/S.
As of December 17, 2021, Søren Møller has joined the board of directors of 21st.BIO A/S.
As of December 17, 2021, Niels Jørgen Kornerup has left the board of directors of 21st.BIO A/S.
As of December 17, 2021, Per Falholt has left the board of directors of 21st.BIO A/S.
As of November 1, 2021, Thomas Troelsgaard Kabel is registered as director of 21st.BIO A/S.
As of November 23, 2020, Niels Jørgen Kornerup has joined the board of directors of 21st.BIO A/S.
On November 23, 2020, the company changed its name from Copenhagen Bio Partners A/S to 21st.BIO A/S.
As of November 19, 2020, Steen Riisgaard has left the board of directors of 21st.BIO A/S.
As of August 1, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 21st.BIO A/S.
As of August 1, 2020, Steen Riisgaard has joined the board of directors of 21st.BIO A/S.
As of August 1, 2020, Thomas Günther Schmidt has joined the board of directors of 21st.BIO A/S.
As of August 1, 2020, Per Falholt has joined the board of directors of 21st.BIO A/S.
As of August 1, 2020, Thomas Günther Schmidt is registered as director of 21st.BIO A/S.
21st.BIO A/S was founded on August 1, 2020.
Companies in the same industry and area
CVR 41454857
CVR 38029096
CVR 10828309
CVR 45343545
CVR 25912357
